Revenue
182 million USD
2026 Q1 · USD
Exact inputs and evidence
- Revenue: 182200000 USD Source
Fundies. English
AVANOS MEDICAL, INC.
EDGARAnnual consolidated revenue for 2025: about USD 701.2M, using the latest reported figures. The previous period, 2024, was about USD 687.8M.
Latest quarter
- Cash and cash equivalents
- 65.6 million USD Source
Exact value
65600000 USD
- Long-term debt including current maturities
- 87.3 million USD Source
Exact value
87300000 USD
- Shares outstanding
- 46.7 million shares Source
Exact value
46673069 shares
Reported share-count change
0.94% · 437 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
716 million USD
2025-04-01 – 2026-03-31
Exact inputs and evidence
Net income
-74.4 million USD
2025-04-01 – 2026-03-31
Exact inputs and evidence
Operating cash flow
36.7 million USD
2025-04-01 – 2026-03-31
Exact inputs and evidence
- Operating cash flow: 32500000 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: 25700000 USD · 2025-01-01 – 2025-03-31 Source
- Operating cash flow: 46500000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: 32500000 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: 74700000 USD · 2025-01-01 – 2025-12-31 Source
- Operating cash flow: 46500000 USD · 2025-01-01 – 2025-09-30 Source
- Operating cash flow: -12300000 USD · 2026-01-01 – 2026-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-05-05.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 11 of 11 periods available· newest 2025-12-31
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 11 of 11 periods available· newest 2025-12-31
- Total liabilities: 11 of 11 periods available· newest 2025-12-31
- Current assets: 11 of 11 periods available· newest 2025-12-31
- Current liabilities: 11 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
- Long-term debt including current maturities: 11 of 11 periods available· newest 2025-12-31
- Shares outstanding: 11 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+1.9%Prior period
USD 687.8 million
–
Current period
USD 701.2 million
–
Exact inputs and evidence
701200000 − 687800000 = 13400000 USD
687800000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source701200000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 319.2 millionPrior period
−USD 392.1 million
–
Current period
−USD 72.9 million
–
Exact inputs and evidence
-72900000 − -392100000 = 319200000 USD
-392100000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-72900000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-25.8%Prior period
USD 100.7 million
–
Current period
USD 74.7 million
–
Exact inputs and evidence
74700000 − 100700000 = -26000000 USD
100700000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source74700000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 701.2 million 100% of revenue
- Cost of revenue USD 347.3 million 50% of revenue
- Operating expenses USD 338.9 million 48% of revenue
- Other operating costs Derived USD 76.6 million 11% of revenue
- Operating income −USD 61.6 million −8.8% of revenue
- Tax, interest and other Derived USD 11.3 million 1.6% of revenue
- Net income −USD 72.9 million −10% of revenue
Cash
- Operating cash flow USD 74.7 million 11% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2016 Operating loss: operating costs were 119% of revenue.
- 2017 Operating loss: operating costs were 107% of revenue.
- 2018 Net income was higher than operating income, so the split is not drawn.
- 2019 Operating loss: operating costs were 108% of revenue.
- 2020 Operating loss: operating costs were 107% of revenue.
- 2021 Operating loss: operating costs were 107% of revenue.
- 2022 Net income was higher than operating income, so the split is not drawn.
- 2023 Net loss: net income was −9.2% of revenue.
- 2024 Operating loss: operating costs were 158% of revenue.
- 2025 Operating loss: operating costs were 109% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | 566200000 | 673300000 Derived | -107100000 | -146900000 Derived | 39800000 | Unavailable | Source
|
| 2017 2017-01-01 – 2017-12-31 | 611600000 | 654700000 Derived | -43100000 | -122400000 Derived | 79300000 | Unavailable | Source
|
| 2018 2018-01-01 – 2018-12-31 | 652300000 | 651800000 Derived | 500000 | -57000000 Derived | 57500000 | Unavailable | Source
|
| 2019 2019-01-01 – 2019-12-31 | 697600000 | 753300000 Derived | -55700000 | -9800000 Derived | -45900000 | Unavailable | Source
|
| 2020 2020-01-01 – 2020-12-31 | 714800000 | 763300000 Derived | -48500000 | -19500000 Derived | -29000000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 587000000 | 626000000 Derived | -39000000 | -45300000 Derived | 6300000 | Unavailable | Source
|
| 2022 2022-01-01 – 2022-12-31 | 684100000 | 648600000 Derived | 35500000 | -15000000 Derived | 50500000 | Unavailable | Source
|
| 2023 2023-01-01 – 2023-12-31 | 673300000 | 669100000 Derived | 4200000 | 66000000 Derived | -61800000 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 687800000 | 1084000000 Derived | -396200000 | -4100000 Derived | -392100000 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 701200000 | 762800000 Derived | -61600000 | 11300000 Derived | -72900000 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 701.2M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 566200000 |
|
| 2017 | Revenue | 611600000 |
|
| 2018 | Revenue | 652300000 |
|
| 2019 | Revenue | 697600000 |
|
| 2020 | Revenue | 714800000 |
|
| 2021 | Revenue | 587000000 |
|
| 2022 | Revenue | 684100000 |
|
| 2023 | Revenue | 673300000 |
|
| 2024 | Revenue | 687800000 |
|
| 2025 | Revenue | 701200000 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
1.9% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | 11.2% |
|
| 2017 | Year over year | 8% |
|
| 2018 | Year over year | 6.7% |
|
| 2019 | Year over year | 6.9% |
|
| 2020 | Year over year | 2.5% |
|
| 2021 | Year over year | -17.9% |
|
| 2022 | Year over year | 16.5% |
|
| 2023 | Year over year | -1.6% |
|
| 2024 | Year over year | 2.2% |
|
| 2025 | Year over year | 1.9% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -8.8% 2025
Net margin -10.4% 2025
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Operating margin | -18.9% |
|
| 2017 | Operating margin | -7% |
|
| 2018 | Operating margin | 0.1% |
|
| 2019 | Operating margin | -8% |
|
| 2020 | Operating margin | -6.8% |
|
| 2021 | Operating margin | -6.6% |
|
| 2022 | Operating margin | 5.2% |
|
| 2023 | Operating margin | 0.6% |
|
| 2024 | Operating margin | -57.6% |
|
| 2025 | Operating margin | -8.8% |
|
| 2016 | Net margin | 7% |
|
| 2017 | Net margin | 13% |
|
| 2018 | Net margin | 8.8% |
|
| 2019 | Net margin | -6.6% |
|
| 2020 | Net margin | -4.1% |
|
| 2021 | Net margin | 1.1% |
|
| 2022 | Net margin | 7.4% |
|
| 2023 | Net margin | -9.2% |
|
| 2024 | Net margin | -57% |
|
| 2025 | Net margin | -10.4% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | Not reported |
|
| 2022 | Free cash flow margin | Not reported |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD 74.7M 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | 188800000 |
|
| 2017 | Operating cash flow | 144200000 |
|
| 2018 | Operating cash flow | -145600000 |
|
| 2019 | Operating cash flow | -74500000 |
|
| 2020 | Operating cash flow | -2500000 |
|
| 2021 | Operating cash flow | 87300000 |
|
| 2022 | Operating cash flow | 90900000 |
|
| 2023 | Operating cash flow | 32400000 |
|
| 2024 | Operating cash flow | 100700000 |
|
| 2025 | Operating cash flow | 74700000 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable |
|
| 2017 | Free cash flow | Unavailable |
|
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | Unavailable |
|
| 2022 | Free cash flow | Unavailable |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
27.5% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 46.8% |
|
| 2017 | Liabilities / assets | 44.7% |
|
| 2018 | Liabilities / assets | 29.2% |
|
| 2019 | Liabilities / assets | 29.7% |
|
| 2020 | Liabilities / assets | 24.9% |
|
| 2021 | Liabilities / assets | 20.8% |
|
| 2022 | Liabilities / assets | 27.7% |
|
| 2023 | Liabilities / assets | 26.9% |
|
| 2024 | Liabilities / assets | 28.2% |
|
| 2025 | Liabilities / assets | 27.5% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
2.15× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 1.83× |
|
| 2017 | Current assets / current liabilities | 2.98× |
|
| 2018 | Current assets / current liabilities | 2.7× |
|
| 2019 | Current assets / current liabilities | 2.53× |
|
| 2020 | Current assets / current liabilities | 2.81× |
|
| 2021 | Current assets / current liabilities | 3.07× |
|
| 2022 | Current assets / current liabilities | 3.27× |
|
| 2023 | Current assets / current liabilities | 2.08× |
|
| 2024 | Current assets / current liabilities | 2.37× |
|
| 2025 | Current assets / current liabilities | 2.15× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2016 2016-01-01 – 2016-12-31 | USD 39.8 million Exact valueExact value: 39800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 188.8 million Exact valueExact value: 188800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2017 2017-01-01 – 2017-12-31 | USD 79.3 million Exact valueExact value: 79300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 144.2 million Exact valueExact value: 144200000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2018 2018-01-01 – 2018-12-31 | USD 57.5 million Exact valueExact value: 57500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 145.6 million Exact valueExact value: -145600000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 45.9 million Exact valueExact value: -45900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 74.5 million Exact valueExact value: -74500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 29 million Exact valueExact value: -29000000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 2.5 million Exact valueExact value: -2500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | USD 6.3 million Exact valueExact value: 6300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 87.3 million Exact valueExact value: 87300000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | USD 50.5 million Exact valueExact value: 50500000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 90.9 million Exact valueExact value: 90900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 61.8 million Exact valueExact value: -61800000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 32.4 million Exact valueExact value: 32400000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 392.1 million Exact valueExact value: -392100000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 100.7 million Exact valueExact value: 100700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 72.9 million Exact valueExact value: -72900000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 74.7 million Exact valueExact value: 74700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
141 filings · 4,753 latest values · 4,753 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001606498, 1606498, AVNS, HYH, edgar:1606498
Also known as AVANOS MEDICAL, INC., Avanos Medical, Inc., HALYARD HEALTH, INC., Halyard Health, Inc.